Literature DB >> 27712766

Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease.

John W Steinke1, Spencer C Payne2, Larry Borish3.   

Abstract

Aspirin-exacerbated respiratory disease (AERD) involves overexpression of proinflammatory mediators, including 5-lipoxygenase and leukotriene C4 synthase (LTC4S), resulting in constitutive overproduction of cysteinyl leukotrienes. Mast cells and eosinophils have roles in mediating many of the observed effects. Increased levels of both interleukin-4 (IL-4) and interferon (IFN)-γ are present in the tissue of patients with AERD. Previous studies showed that IL-4 is primarily responsible for the upregulation of LTC4S by mast cells. Our studies show that IFN-γ, but not IL-4, drives this process in eosinophils. This article examines the overall role that eosinophils and mast cells contribute to the pathophysiology of AERD.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arachidonic acid; Aspirin-exacerbated respiratory disease; Cyclooxygenase; Eosinophil; Leukotriene; Mast cell; Prostaglandin

Mesh:

Substances:

Year:  2016        PMID: 27712766      PMCID: PMC5116300          DOI: 10.1016/j.iac.2016.06.008

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  107 in total

1.  Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle.

Authors:  Laurence Walch; Xavier Norel; Magnus Bäck; Jean-Pierre Gascard; Sven-Erik Dahlén; Charles Brink
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma.

Authors:  J Adamjee; Y-J Suh; H-S Park; J-H Choi; J F Penrose; B K Lam; K F Austen; A M Cazaly; S J Wilson; A P Sampson
Journal:  J Pathol       Date:  2006-07       Impact factor: 7.996

3.  PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors.

Authors:  C Nerlov; T Graf
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

4.  Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease.

Authors:  John W Steinke; Lixia Liu; Phillip Huyett; Julie Negri; Spencer C Payne; Larry Borish
Journal:  J Allergy Clin Immunol       Date:  2013-06-24       Impact factor: 10.793

5.  Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.

Authors:  B Dahlén; E Nizankowska; A Szczeklik; O Zetterström; G Bochenek; M Kumlin; L Mastalerz; G Pinis; L J Swanson; T I Boodhoo; S Wright; L M Dubé; S E Dahlén
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

6.  Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis.

Authors:  E M Minshall; L Cameron; F Lavigne; D Y Leung; D Hamilos; E A Garcia-Zepada; M Rothenberg; A D Luster; Q Hamid
Journal:  Am J Respir Cell Mol Biol       Date:  1997-12       Impact factor: 6.914

7.  Eosinophil-derived IFN-gamma induces airway hyperresponsiveness and lung inflammation in the absence of lymphocytes.

Authors:  Akira Kanda; Virginie Driss; Nicolas Hornez; Marwan Abdallah; Thomas Roumier; Georges Abboud; Fanny Legrand; Delphine Staumont-Sallé; Severine Quéant; Julie Bertout; Sébastien Fleury; Patrick Rémy; Jean-Paul Papin; Valérie Julia; Monique Capron; David Dombrowicz
Journal:  J Allergy Clin Immunol       Date:  2009-06-21       Impact factor: 10.793

8.  Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially.

Authors:  Lisa A Spencer; Craig T Szela; Sandra A C Perez; Casey L Kirchhoffer; Josiane S Neves; Amy L Radke; Peter F Weller
Journal:  J Leukoc Biol       Date:  2008-10-07       Impact factor: 4.962

9.  GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP).

Authors:  D L Hamilos; D Y Leung; D P Huston; A Kamil; R Wood; Q Hamid
Journal:  Clin Exp Allergy       Date:  1998-09       Impact factor: 5.018

10.  Immunohistochemical characterization of cellular infiltrate in nasal polyp from aspirin-sensitive asthmatic patients.

Authors:  H S Park; D H Nahm; K Park; K S Suh; H E Yim
Journal:  Ann Allergy Asthma Immunol       Date:  1998-09       Impact factor: 6.347

View more
  12 in total

Review 1.  Chronic Rhinosinusitis in Children: Pathophysiology, Evaluation, and Medical Management.

Authors:  Jordan Heath; Larry Hartzell; Claire Putt; Joshua L Kennedy
Journal:  Curr Allergy Asthma Rep       Date:  2018-05-29       Impact factor: 4.806

Review 2.  Specialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases.

Authors:  Nandini Krishnamoorthy; Raja-Elie E Abdulnour; Katherine H Walker; Braden D Engstrom; Bruce D Levy
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

Review 3.  Cellular interactions in aspirin-exacerbated respiratory disease.

Authors:  Jana H Badrani; Taylor A Doherty
Journal:  Curr Opin Allergy Clin Immunol       Date:  2021-02-01

Review 4.  Prostaglandins and Their Receptors in Eosinophil Function and As Therapeutic Targets.

Authors:  Miriam Peinhaupt; Eva M Sturm; Akos Heinemann
Journal:  Front Med (Lausanne)       Date:  2017-07-19

5.  Circulating mast cell progenitors correlate with reduced lung function in allergic asthma.

Authors:  Maya Salomonsson; Andrei Malinovschi; Pia Kalm-Stephens; Joakim S Dahlin; Christer Janson; Kjell Alving; Jenny Hallgren
Journal:  Clin Exp Allergy       Date:  2019-06       Impact factor: 5.018

6.  Factors Affecting the Control of Chronic Rhinosinusitis With Nasal Polyps: A Comparison in Patients With or Without NERD.

Authors:  Markus Jukka Lilja; Anni Koskinen; Paula Virkkula; Seija Inkeri Vento; Jyri Myller; Sari Hammarén-Malmi; Anu Laulajainen-Hongisto; Maija Hytönen; Antti Mäkitie; Jura Numminen; Saara Sillanpää; Hannu Raitiola; Markus Rautiainen; Sanna Katriina Toppila-Salmi
Journal:  Allergy Rhinol (Providence)       Date:  2021-04-26

Review 7.  Emerging Biomarkers Beyond Leukotrienes for the Management of Nonsteroidal Anti-inflammatory Drug (NSAID)-Exacerbated Respiratory Disease.

Authors:  Hyo-In Rhyou; Young-Hee Nam; Hae-Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2022-03       Impact factor: 5.764

Review 8.  Innate immune cell dysregulation drives inflammation and disease in aspirin-exacerbated respiratory disease.

Authors:  Ryan Eid; Carol H Yan; Whitney Stevens; Taylor A Doherty; Larry Borish
Journal:  J Allergy Clin Immunol       Date:  2021-08       Impact factor: 14.290

9.  The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease.

Authors:  Suzy A A Comhair; Grazyna Bochenek; Sara Baicker-McKee; Zeneng Wang; Tomasz Stachura; Marek Sanak; Jeffrey P Hammel; Stanley L Hazen; Serpil C Erzurum; Ewa Nizankowska-Mogilnicka
Journal:  Respir Res       Date:  2018-10-30

10.  P2X7R in Mast Cells is a Potential Target for Salicylic Acid and Aspirin in Treatment of Inflammatory Pain.

Authors:  Yucui Jiang; Fan Ye; Ying Du; Yingxin Zong; Zongxiang Tang
Journal:  J Inflamm Res       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.